STAT Plus: Turning Point Therapeutics drug shows benefits for patients with rare lung cancer gene

Turning Point Therapeutics, a San Diego-based developer of targeted cancer drugs, is presenting updated data showing that its targeted therapy helps lung cancer patients whose disease is driven by a?